Jeffrey Switchenko
Assoc Professor
Research Assistant Professor
Faculty, Biostatistics and Bioinformatics
My research background consists of spatial analysis, as a means of identifying populations at risk of developing cancer, and my research focus includes the use of cancer registry data to address population-level research questions. I currently collaborate on clinical and genomic study design and analysis, and I seek to apply statistical methodology to a wide variety of cancer research projects ranging from cancer prevention and control to clinical trials.
Google Scholar: https://scholar.google.com/citations?user=Te0dNngAAAAJ&hl=en
Contact Information
1518 Clifton Road NE
Atlanta , GA 30322
Phone: (404) 778-4157
Email: jswitch@emory.edu
Areas of Interest
- Cancer Prevention
- Exposure Assessment
- Spatial Analysis/GIS
Education
- Ph.D. 2011, Emory University
- M.S. 2010, Emory University
- B.S. 2006, Bowdoin College
Courses Taught
- BIOS 506: Foundations BIOS Methods
Publications
- Shishir K Maithel, Jessica M Keilson, Hop S Tran Cao, Manali Rupji, Amit Mahipal, Bruce S Lin, Milind M Javle, Sean P Cleary, Mehmet Akce, Jeffrey M Switchenko, Flavio G Rocha, 2023, NEO-GAP: A single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma , Annals of Surgical Oncology, ,
- Tim Niyogusaba, Jeffrey M Switchenko, Sima Rozati, Swaminathan Padmanabhan Iyer, Sai Talluru, etc,., 2023, Investigating the impact of demographic disparities on clinical outcomes in cutaneous T-cell lymphoma (CTCL): A multicenter retrospective cohort analysis., Journal of Clinical Oncology, 41, 7573
- Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera, Mehmet A Bilen, Taofeek K Owonikoko, Jonathan L Kaufman, Ajay K Nooka, Colleen M Lewis, Elise Hitron, Hannah Collins, Emma C Judson, Olatunji B Alese, R Donald Harvey, Jennifer W Carlisle, 2023, Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast, The Oncologist, ,
- Troy Kleber, J Switchenko, D Lawson, ZS Buchwald, MK Khan , 2022, Real World Outcomes of Melanoma Brain Metastases Treated with Immunotherapy with or without Stereotactic Radiosurgery, International Journal of Radiation Oncology, Biology, Physics, 114, e56
- Sibo Tian, Jeffrey M Switchenko, Zachary S Buchwald, Pretesh R Patel, Joseph W Shelton, Shannon E Kahn, etc,., 2020, Lung stereotactic body radiation therapy and concurrent immunotherapy: a multicenter safety and toxicity analysis, International Journal of Radiation Oncology* Biology* Physics, 108, 304-313
- Sibo Tian, Jeffrey M Switchenko, Jaymin Jhaveri, Richard J Cassidy, Matthew J Ferris, Robert H Press, etc,., 2019, Survival outcomes by high?risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: a propensity?scored analysis of the National Cancer Data Base, Cancer, 125, 2782-2793
- Mudit Chowdhary, Jeffrey M Switchenko, Robert H Press, Jaymin Jhaveri, Zachary S Buchwald, etc,., 2018, Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery, Journal of neuro-oncology, 139, 689-697
- Richard J Cassidy, Jeffrey M Switchenko, Naresh Jegadeesh, Mutlay Sayan, Matthew J Ferris, etc,., 2017, Association of lymphovascular space invasion with locoregional failure and survival in patients with node-negative oral tongue cancers, JAMA Otolaryngology–Head & Neck Surgery, 143, 382-388
- Jeffrey M Switchenko, Catherine Bulka, Kevin Ward, Jean L Koff, A Rana Bayakly, P Barry Ryan, Lance A Waller, Christopher R Flowers, 2016, Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma, Cancer epidemiology , 41, 139-151
- Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, etc,., 1945, Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma, Blood advances, 7, 2287-2296